Oligonucleotide CDMO

Oligonucleotide CDMO
Krystal Beily

Lopinion by

Krystal Beily

May 29, 2023

It's demanding work for biotech companies to carry out Oligonucleotide CDMO for both research and commercial needs.

Oligonucleotide cdmo capabilities include but are not limited to:

DNA Oligos
UNA and TINA oligonucleotides
Light-activated oligonucleotides
Chimeric oligonucleotides
Various modified or unmodified antisense oligonucleotides
Polypeptide-Nucleotide Conjugates
RNA Oligos

Chimeric oligonucleotides
Long RNA synthesis
CRISPR guide strand (sgRNA) synthesis
siRNA and UsiRNA
Nano self-assembled RNA drugs

Comments (0)

You must Register or Login to post a comment

1000 Characters left

Copyright © GLBrain 2023. All rights reserved.